Investment– tag –
-
Big Pharma Mega Deals in the Last Few Months Series Part 6 | A Startup-Side Playbook: Building a Company That Can Partner or Stay Independent
In the previous installments of this series, we looked at recent big pharma transactions through the lenses of oncology, obesity/metabolic disease, re In the previous installments of this series, we looked at recent big pharma transactio... -
Beyond Headline Numbers: A 3-Axis Framework for Reading Big Pharma Mega Deals (Investor Lens)
When investors follow big pharma transactions, it is tempting to focus on headline numbers: total deal value, takeover premium, “multi-billion” labels. When investors follow big pharma transactions, it is tempting to focus on headline nu... -
Series “Reading 2025 Layoffs”: 2025 Biotech/Pharma Layoffs at a Glance: What Happened and Where It Concentrated (Part 1)
Category: Pharma & Biotech NEWS | Series “Reading 2025 Layoffs” — Part 1 What you will learn Key TakeawaysPurpose & Scope2025 SnapshotPatterns by Company SizeWhy It Happened: Five Drivers Key Takeaways Selectivity & Focus: La...
1